The postmenopausal hormone replacement therapy-related breast cancer risk is decreased in women carrying the CYP2C19*17 variant
2011 ◽
Vol 131
(1)
◽
pp. 347-350
◽
2008 ◽
Vol 19
(2)
◽
pp. 123-126
2000 ◽
Vol 20
(3)
◽
pp. 308-313
◽
2003 ◽
2008 ◽
2006 ◽
Vol 900
(1)
◽
pp. 422-428
◽
Keyword(s):
1998 ◽
Vol 147
(8)
◽
pp. 718-721
◽
2000 ◽
Vol 70
◽
pp. B10-B10
2007 ◽
Vol 25
(31)
◽
pp. 5038-5039
◽